After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.
Sears should be embarrassed by the state of its New York City stores.
As Thursday's breakdown develops, CVS will face a very important test.
The retailer's recent price weakness is an opportunity for investors to act.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.